Procto-glivenol Cream, 30 g

Procto-glivenol cream 30g

Name ENG

PROCTO-GLYVENOL

Clinical and pharmacological group

A drug with venotonic, anti-inflammatory and local anesthetic action for local use in proctology

ATX code

Other drugs and their combinations

Dosage

2.12g / 100g + 5g / 100g x 30g

Structure

1 g of cream contains: tribenoside 50 mg, lidocaine hydrochloride 20 mg.

Indications

Hemorrhoids (internal and external).

INN / Active ingredient

Lidocaine, Tribenoside

Contraindications

Hypersensitivity to the components of the drug, liver failure, pregnancy (I trimester).

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 5 years

Specifications

Category

Hemorrhoids

Scope of the drug

Gastrointestinal tract

Release form

Cream

Manufacturer country

Italy

Package quantity, pcs

one

Scope of application

Proctology

Way of introduction

Locally

,

Outwardly

,

Rectally

Vacation conditions

Without recipe

Brand name

Recordati H. & F. industry S.p.A.

Components

cap-nozzle, polyethylene tip

The amount of the dosage form in the primary package

30 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Hemorrhoid remedy

Dosage form

Rectal cream

Packaging

Box

The target audience

Adult

Expiration date in days

1826

Package weight, g

thirty

Mode of application

:

The drug is prescribed rectally in the form of a cream in the morning and in the evening until the expressed clinical symptoms disappear.

With regression of acute symptoms, the frequency of use can be reduced to 1 time / day.

For internal hemorrhoids, the cream is injected using a nozzle.

30 g of cream (1 tube) is enough for about 20-30 rectal injections.

Anatomical and therapeutic characteristics

:

C05AX03 Preparations for the treatment of hemorrhoids and anal fissures in combination

Dosage (volume) of the substance in the preparation

:

100 g: tribenoside 5 g, lidocaine hydrochloride (in the form of a hydrate) 2.12 g, which corresponds to the content of anhydrous lidocaine hydrochloride 2 g